Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 470 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 251-275 of 390 matching filings.

Per page
25
Current page
11
NT 10-K File 333-68008

FORM 12B-25 (NT 10-K)

Filing date
14 Jul 2016
Reporting date
30 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
03 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 333-68008

FORM 10-K - AMENDMENT 3

Filing date
02 Mar 2016
Reporting date
30 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
28 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 333-68008

AMENDMENT NO. 2

Filing date
19 Jan 2016
Reporting date
30 Apr 2015
Next action
Verify source filing
10-Q/A File 333-68008

AMENDMENT NO. 2

Filing date
19 Jan 2016
Reporting date
31 Oct 2015
Next action
Verify source filing
D File 021-255391

D filing

Filing date
19 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 333-68008

AMENDMENT NO. 1

Filing date
19 Jan 2016
Reporting date
31 Oct 2015
Next action
Verify source filing
10-Q/A File 333-68008

AMENDMENT NO. 1

Filing date
19 Jan 2016
Reporting date
31 Jul 2015
Next action
Verify source filing
10-K/A File 333-68008

AMENDMENT NO. 1

Filing date
19 Jan 2016
Reporting date
30 Apr 2015
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
12 Jan 2016
Reporting date
07 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

CURRENT REPORT

Filing date
31 Dec 2015
Reporting date
30 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

CURRENT REPORT

Filing date
02 Nov 2015
Reporting date
29 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
02 Oct 2015
Reporting date
28 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-68008

QUARTERLY REPORT

Filing date
25 Aug 2015
Reporting date
31 Jul 2015
Next action
Verify source filing
10-K File 333-68008

ANNUAL REPORT

Filing date
29 Jul 2015
Reporting date
30 Apr 2015
Next action
Verify source filing
NT 10-K File 333-68008

NOTICE OF LATE FILING

Filing date
14 Jul 2015
Reporting date
30 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

PHARMACYTE BIOTECH, INC.

Filing date
28 May 2015
Reporting date
26 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
29 Apr 2015
Reporting date
27 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-68008

CT ORDER filing

Filing date
20 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .